These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
264 related articles for article (PubMed ID: 25982631)
1. The role of the dynorphin/κ opioid receptor system in anxiety. Hang A; Wang YJ; He L; Liu JG Acta Pharmacol Sin; 2015 Jul; 36(7):783-90. PubMed ID: 25982631 [TBL] [Abstract][Full Text] [Related]
2. The Role of Dynorphin and the Kappa Opioid Receptor in the Symptomatology of Schizophrenia: A Review of the Evidence. Clark SD; Abi-Dargham A Biol Psychiatry; 2019 Oct; 86(7):502-511. PubMed ID: 31376930 [TBL] [Abstract][Full Text] [Related]
3. The dysphoric component of stress is encoded by activation of the dynorphin kappa-opioid system. Land BB; Bruchas MR; Lemos JC; Xu M; Melief EJ; Chavkin C J Neurosci; 2008 Jan; 28(2):407-14. PubMed ID: 18184783 [TBL] [Abstract][Full Text] [Related]
4. Characterization of kappa opioid receptor mediated, dynorphin-stimulated [35S]GTPγS binding in mouse striatum for the evaluation of selective KOR ligands in an endogenous setting. Zhou L; Stahl EL; Lovell KM; Frankowski KJ; Prisinzano TE; Aubé J; Bohn LM Neuropharmacology; 2015 Dec; 99():131-41. PubMed ID: 26160155 [TBL] [Abstract][Full Text] [Related]
5. Kappa-Opioid Antagonists for Psychiatric Disorders: From Bench to Clinical Trials. Carlezon WA; Krystal AD Depress Anxiety; 2016 Oct; 33(10):895-906. PubMed ID: 27699938 [TBL] [Abstract][Full Text] [Related]
6. Dynorphin activation of kappa opioid receptor reduces neuronal excitability in the paraventricular nucleus of mouse thalamus. Chen Z; Tang Y; Tao H; Li C; Zhang X; Liu Y Neuropharmacology; 2015 Oct; 97():259-69. PubMed ID: 26056031 [TBL] [Abstract][Full Text] [Related]
8. Dynorphin A1-13 causes elevation of serum levels of prolactin through an opioid receptor mechanism in humans: gender differences and implications for modulation of dopaminergic tone in the treatment of addictions. Kreek MJ; Schluger J; Borg L; Gunduz M; Ho A J Pharmacol Exp Ther; 1999 Jan; 288(1):260-9. PubMed ID: 9862779 [TBL] [Abstract][Full Text] [Related]
9. Dynorphin/kappa-opioid receptor control of dopamine dynamics: Implications for negative affective states and psychiatric disorders. Tejeda HA; Bonci A Brain Res; 2019 Jun; 1713():91-101. PubMed ID: 30244022 [TBL] [Abstract][Full Text] [Related]
11. Kappa-opioid receptor-mediated modulation of innate immune response by dynorphin in teleost Channa punctatus. Singh R; Rai U Peptides; 2010 May; 31(5):973-8. PubMed ID: 20132853 [TBL] [Abstract][Full Text] [Related]
12. Amygdala dynorphin/κ opioid receptor system modulates depressive-like behavior in mice following chronic social defeat stress. Zan GY; Sun X; Wang YJ; Liu R; Wang CY; Du WJ; Guo LB; Chai JR; Li QL; Liu ZQ; Liu JG Acta Pharmacol Sin; 2022 Mar; 43(3):577-587. PubMed ID: 34035484 [TBL] [Abstract][Full Text] [Related]
16. Mother root of Aconitum carmichaelii Debeaux exerts antinociceptive effect in Complet Freund's Adjuvant-induced mice: roles of dynorpin/kappa-opioid system and transient receptor potential vanilloid type-1 ion channel. Wang C; Sun D; Liu C; Zhu C; Jing X; Chen S; Liu C; Zhi K; Xu T; Wang H; Liu J; Xu Y; Liu Z; Lin N J Transl Med; 2015 Aug; 13():284. PubMed ID: 26320055 [TBL] [Abstract][Full Text] [Related]
17. κ Opioid Receptor-Dynorphin Signaling in the Central Amygdala Regulates Conditioned Threat Discrimination and Anxiety. Baird MA; Hsu TY; Wang R; Juarez B; Zweifel LS eNeuro; 2021; 8(1):. PubMed ID: 33323398 [TBL] [Abstract][Full Text] [Related]
18. Dynorphin regulates the phagocytic activity of splenic phagocytes in wall lizards: involvement of a κ-opioid receptor-coupled adenylate-cyclase-cAMP-PKA pathway. Kumar S; Rai U J Exp Biol; 2011 Dec; 214(Pt 24):4217-22. PubMed ID: 22116765 [TBL] [Abstract][Full Text] [Related]
19. Relative contribution of endogenous opioids to myocardial ischemic tolerance. Romano MA; Seymour EM; Berry JA; McNish RA; Bolling SF J Surg Res; 2004 May; 118(1):32-7. PubMed ID: 15093714 [TBL] [Abstract][Full Text] [Related]
20. Low dosage of rimonabant leads to anxiolytic-like behavior via inhibiting expression levels and G-protein activity of kappa opioid receptors in a cannabinoid receptor independent manner. Zádor F; Lénárt N; Csibrány B; Sántha M; Molnár M; Tuka B; Samavati R; Klivényi P; Vécsei L; Marton A; Vizler C; Nagy GM; Borsodi A; Benyhe S; Páldy E Neuropharmacology; 2015 Feb; 89():298-307. PubMed ID: 25446673 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]